INS and Alzheimer disease: As mentioned in Section 2.1, a number of studies, as recently reviewed, reveal an increased risk of developing AD in T2DM patients, and the two diseases share common features, spanning from the alteration of insulin signaling and glucose metabolism to insulin resistance and inflammation [102,103,104,105].